Prosecution Insights
Last updated: April 19, 2026

4D Molecular Therapeutics Inc.

2 pending office actions

Portfolio Summary

2
Total Pending OAs
0
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18042517 CODON OPTIMIZED RPGRORF15 GENES AND USES THEREOF MCCORMICK, CATHERINE LYNN 1638 Non-Final OA Feb 22, 2023
18052735 CODON OPTIMIZED REP1 GENES AND USES THEREOF ARON, KIMBERLY A 1633 Non-Final OA Nov 04, 2022

Managing 4D Molecular Therapeutics Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month